Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed May 11, 2021 · 10-Q · 41 days after period end · 0001564590-21-026309
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$34.84M | -$20.14M | -$1.25M | -$254.00K |
| EPS Diluted | -$0.96 | -$0.62 | -$0.19 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 11, 2021 · 41 d after period end
